Jenifer Axline, director of innovative technology at Novation said, As the health care industry’s leading contracting company, we want to ensure that members can receive preferred pricing on the latest innovations in medical technology. By adding the TomoTherapy® Hi·Art treatment system to our comprehensive radiation oncology portfolio, members will be able to purchase, under contract, the next generation of cancer treatment products.
The TomoTherapy Hi·Art treatment system is the only radiation therapy solution to use a CT-style ring gantry design, CT-based image guidance and two distinct delivery modes that share an efficient, consistent treatment planning and delivery process. TomoHelicalSM mode enables delivery from all angles around the patient in multiple, 360-degree rotations. The new TomoDirectSM mode allows clinicians to choose up to 12 discrete angles for treatment delivery. The choice of which modality to use for a given case depends on the nature of the tumor volume and surrounding organs at risk.
Robertson said, Novation is a well-respected group purchasing organization, and we are confident that our agreement with them will open doors to a wide range of new institutions. We look forward to working with Novation to demonstrate for VHA, UHC and Provista members how the Hi·Art system gives them flexibility to treat the widest range of cancer cases—from the most routine to the most complex—in a straight-forward, high-quality fashion.
